GSK Taps ABL Bio’s Brain-Shuttle Tech in $3B+ Deal
South Korea’s ABL Bio, a biotech company specializing in bispecific antibodies, has signed a major licensing agreement with…
ABL Bio
2 개의 기사가 있습니다.
ABL Bio Confident in Technology Transfer This Year, Secures $310 million for Development
ABL Bio has announced its ambition to become a global leader in the targeted cancer therapy market through…